Small Molecules
Accelerating Your Drug Development from Discovery to Clinic
We specialize in providing comprehensive small molecule drug development services. With a dedicated team of over 2,000 researchers and scientists, we offer integrated solutions from early discovery through preclinical testing to accelerate your therapeutic development journey.
Comprehensive Preclinical Capabilities
Our AAALAC-accredited vivarium spans 30,000 sq. ft. and houses 38 specialized animal rooms,
ensuring the highest standards of animal care and research quality.
Anthem Biosciences offers a complete suite of preclinical services:
Regulatory Toxicology
Acute, sub-acute, sub-chronic, and chronic toxicity assessments to meet global regulatory requirements.
Reproductive Toxicology
Studies evaluating the effects of substances on reproductive health and development.
Genetic Toxicology
In vitro and in vivo assays to assess mutagenic and genotoxic potential.
Safety Pharmacology
Cardiovascular, central nervous system, and respiratory safety evaluations.
In Vitro Alternate Assays
Ethical and scientifically sound testing for skin and eye irritation, corrosion, and sensitization.
DMPK (Drug Metabolism and Pharmacokinetics)
Comprehensive studies on drug absorption, distribution, metabolism, and excretion.
In Vivo Pharmacology
Efficacy testing using relevant animal models.
Specialized Services
Anthem offers process research & developments labs, pilot plant/kilo lab, Hydrogenation suits, Peptides
facility, Hi-potent facility, Biological facility equipped with advancedtechnologies to develop, optimize
& scale pharmaceutical processes from lab scale to commercial manufacturing.
For advanced research testing, discover the following services:
Bacterial Identification and Strain Typing
Utilizing Matrix Assisted Laser Desorption/Ionization – Time of Flight (MALDI-TOF) mass spectrometry and 16S rRNA sequencing for precise microbial identification and strain typing, ensuring accuracy for clinical, industrial, and environmental studies.
Drug Metabolism and Pharmacokinetics (DMPK)
DMPK testing services to evaluate the pharmacokinetic profile and safety of drug candidates. The DMPK testing helps optimize drug development by assessing key parameters that influence absorption, distribution, metabolism, and excretion (ADME).
Cell-Based Assays
Services to enhance the development of novel therapeutics, test for potency and efficacy, screen for targeted therapeutic antibodies, and accelerate the development of innovative therapies.
Why Partner with Anthem for Small Molecules?
Deep Scientific Expertise
Our team of experienced researchers and scientists provides comprehensive support throughout the preclinical testing process.
Regulatory Compliance
We adhere to OECD-GLP standards and global regulatory guidelines, ensuring the reliability and acceptance of your preclinical data.
Customized Solutions
We tailor our services to meet the specific needs of each project, providing flexible and efficient solutions.
Accelerated Development
Our integrated approach and advanced technologies help expedite the preclinical development process, saving time and resources.
